Combined treatment for bile duct cancer
Part of Cancer, Digestive system clinical trials.
This trial is testing a new approach for people with bile duct cancer that cannot be removed by surgery. It combines a procedure that uses heat to destroy cancer cells inside the bile duct with standard radiation therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 20 years or older.
- You must have bile duct cancer that was confirmed by a biopsy and cannot be surgically removed.
- Your cancer must not have spread to other organs (stage IV) or caused fluid buildup in the belly (malignant ascites).
- You must be able to undergo an endoscopic procedure (a thin tube passed through your mouth to reach the bile duct).
- You must not have a pacemaker, be pregnant, or have a bleeding problem that cannot be corrected.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new combination of two drugs (recaticimab and adebrelimab) with standard chemotherapy for people with bile duct or gallbladder cancer that cannot be removed by surgery. The goal is to see if this combination helps shrink tumors and slow the cancer's growth.
This trial tests a minimally invasive treatment using heat (radiofrequency ablation) to destroy cancer cells in the bile duct. It's for patients whose bile duct cancer cannot be removed by surgery and who are also receiving systemic therapy.
This trial tests a procedure that uses heat (radiofrequency ablation) to treat bile duct cancer that can't be removed by surgery. If you have this type of cancer and are starting standard treatment, this study wants to see if adding this heat treatment is safe and might help.
This trial tests a combination of heat therapy inside the bile duct (endobiliary RFA) with immunotherapy (durvalumab) and chemotherapy (gemcitabine and cisplatin) for people with unresectable extrahepatic cholangiocarcinoma. The goal is to see if adding the heat treatment improves outcomes.
This trial combines a liver-directed radiation therapy (radioembolization) with a targeted drug to treat a specific type of bile duct cancer that cannot be surgically removed. The goal is to see if this combination can shrink the tumor and improve outcomes.
This trial tests a combination of two chemotherapy drugs and an immunotherapy drug, followed by targeted radiation, in people with bile duct or gallbladder cancer that cannot be removed with surgery. The goal is to see if this approach can shrink tumors and improve outcomes.
Hear when a new Biliary Tract Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.